Erector Spinae Block: How It Works, Benefits, and Techniques

The erector spinae plane block is a regional anesthesia technique in which a local anesthetic is injected beneath the erector spinae muscles of the back, near the spine, to numb pain-carrying nerves across a broad swath of the trunk. First described in 2016 for thoracic neuropathic pain, it has quickly become one of the most widely adopted fascial plane blocks in surgery and trauma care, largely because it is technically straightforward and sits far from the spinal cord and major blood vessels. The block’s appeal comes with a caveat, though: how far the anesthetic actually spreads, and therefore how complete the pain relief turns out to be, varies from patient to patient in ways that are still not fully understood.

What Happens When the Needle Goes In

The erector spinae muscles run in thick columns along either side of your spine, anchored to the vertebrae’s bony projections called transverse processes. During an ESP block, an anesthesiologist uses an ultrasound probe to visualize these muscles and the transverse process beneath them, then advances a needle until its tip sits in the tissue plane between muscle and bone. A dose of local anesthetic, typically ropivacaine or bupivacaine, is injected into that plane. On the ultrasound screen, the clinician can watch the fluid lift the muscle away from the bone, confirming correct placement.

The injection target distinguishes the ESP block from a related technique called the retrolaminar block, which deposits the drug closer to the vertebral laminae rather than the transverse processes. That small anatomical difference changes how the anesthetic tracks through surrounding tissues.¹

How It Actually Produces Pain Relief

The primary mechanism is direct contact between the local anesthetic and nerves that run through or near the fascial plane deep to the erector spinae muscles. Once injected, the drug seeps through connective tissue layers and reaches the dorsal rami, which are the nerve branches supplying the back itself, and in many patients also reaches the ventral rami, which carry sensation from the chest and abdominal wall. Spread into the paravertebral space, the compartment just alongside the spinal column where spinal nerves emerge, is the most clinically important route because it blocks the nerves before they branch out to the skin and deeper tissues.²

A systematic review of anatomical studies found that the injected fluid consistently spreads along the erector spinae plane itself, covering an average of about nine spinal levels. But forward penetration into the paravertebral space occurred in only about 57% of subjects, and spread into the epidural space, the region around the spinal cord, was even less common.³ Dorsal rami blockade is the most reliable result. That means the back pain component of a surgical incision is almost always covered, but the deeper, anterior pain from organs or the front of the chest wall depends on whether the drug penetrates far enough forward in a given patient.

Other proposed mechanisms include systemic absorption of the anesthetic into the bloodstream, which might produce a mild whole-body analgesic effect, and immunomodulatory properties of local anesthetics that could dampen the inflammatory cascade after surgery. These are considered secondary contributors at most.²

Where the Block Is Used in Practice

The ESP block has been applied across an unusually wide range of surgeries for a technique that is barely a decade old. Its strongest evidence base is in thoracic, abdominal, and cardiac procedures.

Thoracic Surgery

Video-assisted thoracoscopic surgery, commonly called VATS, is one of the most studied settings. A randomized trial found that patients who received an ESP block had meaningfully lower pain scores in the first six hours after surgery compared to those who received only standard intravenous pain medication, and they needed about half the rescue opioid dose in the recovery room.⁴ Another trial in VATS patients showed that the block cut the median demand for strong opioids by roughly a third compared with intravenous analgesia alone.⁵ A pilot observational study reported that patients receiving an ESP block after VATS consumed a median of only 5.5 mg of intravenous morphine equivalents in the first 24 hours and more than half reported “much improvement” by 12 hours after surgery.⁶

Abdominal Surgery

Laparoscopic cholecystectomy, one of the most commonly performed abdominal operations, has been a testing ground for the block in the abdomen. A trial comparing an ESP block against simple port-site local anesthetic infiltration found that the block group needed significantly less morphine over 24 hours and reported lower pain scores at rest and with movement through 12 hours.⁷ A separate double-blind trial measuring overall recovery quality found that patients receiving the block scored substantially higher on a standardized recovery questionnaire and consumed far less tramadol: a median of zero milligrams versus 180 mg in the control group within the first day.⁸ A meta-analysis comparing the ESP block to the transversus abdominis plane block, a well-established abdominal wall block, found moderate evidence that the ESP block reduced pain severity and opioid use more effectively in the early postoperative window.⁹

Cardiac Surgery

Open heart surgery through a sternotomy produces intense postoperative pain, and managing it without heavy opioid use is a priority for early recovery. A meta-analysis of randomized trials found that ESP blocks reduced postoperative opioid consumption after cardiac surgery, shortened the time patients spent on a ventilator, and facilitated earlier discharge from the ICU.¹⁰ A broader systematic review echoed those findings, also noting less opioid-related itching in patients who received the block.¹¹

Lumbar Spine Surgery

Not every surgical context favors the block equally. A randomized, double-blind trial in patients undergoing lumbar spine surgery found no significant difference in 24-hour morphine consumption between patients who received an ESP block with ropivacaine and those who received a sham injection with saline. Pain scores and opioid-related side effects were also similar through five postoperative days.¹² The lumbar region’s thicker muscle layers and different fascial anatomy may limit how effectively the anesthetic reaches the target nerves at those levels.

Rib Fractures and Emergency Department Use

Broken ribs are agonizingly painful, and the pain itself is dangerous because it keeps patients from breathing deeply, raising the risk of pneumonia. The ESP block has emerged as a practical option here because it can be performed at the bedside with portable ultrasound and does not require the patient to sit up and lean forward the way a thoracic epidural does. A scoping review of studies in acute rib fractures found a roughly 40% decrease in pain scores within the first 24 hours after the block and improvements in breathing measurements like incentive spirometry in the studies that tracked lung function.¹³

A randomized controlled trial in the emergency department confirmed these results: patients who received the block had significantly lower pain scores at rest and during deep breaths at 30, 60, and 120 minutes compared to a sham procedure, and they required about half the rescue analgesic dose.¹⁴ Another study specifically looked at whether non-specialist emergency physicians could safely perform the block in rib fracture patients. Pain scores dropped significantly, daily opioid use fell, and breathing muscle strength roughly doubled within 24 hours. No complications, readmissions, or adverse events occurred.¹⁵

How It Stacks Up Against Epidural and Paravertebral Blocks

The thoracic epidural has long been considered the gold standard for chest and upper abdominal pain management. It works reliably, but it requires placing a needle very close to the spinal cord, carries risks of low blood pressure and epidural hematoma, and is contraindicated in patients on blood thinners. The ESP block’s key selling point is that it avoids all of these concerns.

Head-to-head comparisons have been encouraging. A prospective trial in cardiac surgery patients found comparable pain scores between the ESP block and thoracic epidural at all time points through 12 hours, with only a slight epidural advantage at 24 to 48 hours, though even then average pain remained below the threshold most clinicians consider acceptable. Importantly, the ESP block caused significantly less hypotension.¹⁶ A non-inferiority trial in VATS patients found that a continuous ESP block matched the epidural on recovery quality scores across three postoperative days, formally meeting the non-inferiority threshold.¹⁷ In patients with traumatic flail chest, the ESP block provided equivalent pain relief and similar improvements in lung function as the epidural, again with better blood pressure stability and fewer side effects.¹⁸

The paravertebral block sits somewhere between the epidural and the ESP block in terms of invasiveness. A large meta-analysis found that overall outcomes like resting pain scores, time to first rescue analgesic, and quality of recovery were similar between paravertebral and ESP blocks across thoracic, breast, kidney, and abdominal surgeries.¹⁹ However, a recent multicenter trial in major breast cancer surgery found that the ESP block failed to meet non-inferiority criteria against the paravertebral block: more patients in the ESP group needed morphine, and importantly, the ESP block failed to cover the required skin area in over half of participants compared with about a fifth in the paravertebral group.²⁰ This underscores a recurring theme: the ESP block’s coverage of the front of the chest can be unreliable compared to blocks that deposit anesthetic directly alongside the spinal nerves.

Adjuvant Drugs That Extend the Block

A single-shot ESP block typically wears off within several hours, and researchers have explored adding drugs to the local anesthetic to stretch that window. The two most studied adjuvants are dexmedetomidine, a sedative with pain-relieving properties, and dexamethasone, a steroid with anti-inflammatory effects.

A randomized trial in patients undergoing total knee replacement compared both adjuvants to a plain local anesthetic ESP block. Both dexamethasone and dexmedetomidine nearly doubled the time before patients first requested an opioid, from about 8 hours in the control group to roughly 14 and 12 hours, respectively. Dexamethasone came out ahead overall, producing lower total opioid use and better pain scores without increasing side effects.²¹ A trial in thoracoscopic lobectomy found that adding dexmedetomidine significantly prolonged sensory blockade and delayed the first use of patient-controlled analgesia compared with both plain ropivacaine and ropivacaine with dexamethasone.²² The overall picture is that both adjuvants help, but which one edges ahead may depend on the surgical context and what outcome matters most.

For procedures where pain management needs to extend over days rather than hours, a continuous catheter can be threaded into the erector spinae plane to deliver ongoing infusions. This technique has been reported in settings from major abdominal surgery in adults to thoracotomy in infants as young as seven months, where the catheter provided effective pain relief without any need for opioid rescue.²³ Adding dexamethasone to a continuous ESP block regimen in lung surgery patients lowered resting and coughing pain scores through 72 hours, cut tramadol consumption substantially, and shortened hospital stays by nearly a full day compared with the continuous block alone.²⁴

Use in Children

Pediatric anesthesiologists were among the early adopters of the ESP block, in part because children’s smaller body size and thinner muscle layers make the ultrasound landmarks particularly clear. A narrative review noted the block has been applied in pediatric thoracic, abdominal, hip, and femur surgeries using single-shot, intermittent bolus, and continuous infusion approaches, with outcomes comparable to other regional techniques.²⁵

A systematic review and meta-analysis of pediatric trials found that children who received an ESP block used less opioid medication both during and after surgery, waited over two hours longer before needing their first pain medication, and had lower rates of nausea and vomiting compared to those managed with systemic analgesia alone.²⁶ In pediatric cardiac surgery specifically, the block reduced cumulative opioid consumption through 48 hours, though it did not significantly shorten ICU or hospital stays.²⁷

Safety Profile

One of the block’s biggest draws is its complication rate, which is very low. The needle enters a muscular compartment that contains no major blood vessels, no pleura at the thoracic level when performed correctly, and no spinal cord. The largest retrospective safety study examined 342 consecutive ESP blocks performed for lumbar spine surgery and found zero cases of sensory loss, motor weakness, bleeding complications, or dangerous blood pressure changes. The only complication identified was a single small pneumothorax in a patient whose block was placed at the T12 level, near the lung’s lower boundary.²⁸

Blood thinners are one of the most important practical advantages. Epidural and paravertebral blocks carry a real risk of bleeding into tight spaces near the spinal cord, so they are often avoided in patients on anticoagulant therapy. The ESP block’s superficial location makes it a much safer choice in these patients, which is one reason it has gained traction in cardiac surgery, where blood thinners are nearly universal.

Why Coverage Can Be Unpredictable

For all its advantages, the ESP block has a reliability problem that the literature is increasingly honest about. The extent of sensory loss it produces on the chest and abdominal wall is highly variable from one patient to the next and imperfectly correlated with how far the injected fluid appears to spread on imaging.²⁹ The fundamental issue is anatomical: because the drug is deposited in a relatively superficial layer and must percolate through fascial barriers to reach the paravertebral space where the key nerves sit, individual differences in how those fascia connect and how permeable they are can dramatically change the result.

A narrative review comparing the ESP block to the paravertebral block framed this as a core trade-off. The paravertebral block delivers anesthetic right next to the spinal nerves, producing consistent blockade but placing the needle close to the pleura and blood vessels. The ESP block works from a safer, more superficial plane but relies on unpredictable forward drug migration to reach those same nerves. Fascial plane variability, differences between spinal segments, and even patient body composition all influence outcomes.³⁰ This is why the breast surgery trial described earlier found the ESP block failed to cover the expected skin territory in over half of patients. For operations where the surgical field is primarily posterior, like back surgery or rib fractures, the block’s reliable dorsal rami coverage is usually sufficient. For operations centered on the front of the chest or deep abdomen, the hit-or-miss paravertebral penetration becomes a clinically meaningful limitation.

Chronic Pain and Cancer Pain

Beyond the operating room, clinicians have begun exploring the ESP block for chronic and cancer-related pain. Reports describe its use in chronic thoracic pain, abdominal visceral pain from cancer, and pain from bone metastases. Both single-shot and continuous catheter techniques have been used, and a small number of cases have involved neurolytic agents, chemicals that destroy nerve tissue, for longer-lasting relief in patients with terminal illness.³¹ A review of the block’s chronic pain applications noted that ultrasound guidance has made repeated or continuous blocks more practical in outpatient settings, though the technique still lacks large controlled trials in this population.³²

The evidence here is early-stage. Most published data come from case reports and small case series without control groups, so it is hard to say how much of the reported benefit reflects the block itself versus placebo effects or the natural course of the disease. Researchers recognize this gap, and controlled trials in chronic pain populations are starting to appear. For now, the block is most defensible as a component of multimodal pain management for patients who cannot tolerate or have exhausted other options.

Training and the Learning Curve

Part of what has driven the ESP block’s rapid adoption is how quickly clinicians can learn to perform it. The ultrasound landmarks are clear: a bright, flat transverse process with a thick layer of muscle on top. There is no need to identify subtle tissue boundaries the way some deeper nerve blocks require. A training study involving emergency medicine physicians, most of whom had never performed the block, found that after a single hands-on session with a simulation model, every participant reported improved confidence, knowledge, and skills to perform it independently.³³ That accessibility is a genuine advantage in settings like emergency departments and smaller hospitals, where anesthesiology specialists may not always be available and patients with rib fractures or surgical pain still need effective regional analgesia.